Search results for "ffpe challenges"
Selected Filters:
High-content imaging for diverse 3D cell culture models
Modernizing dioxin and POPs analysis
Spark Cyto with new 3D analysis tools
A standardized, automated, rapid platform for biomarker discovery
Tropic Biosciences partners with BASF to develop innovative traits for growers
BASF to utilize Tropic Bio's GEiGS (Gene Editing induced Gene Silencing) technology to develop strategic crop varieties with improved resistance to disease and pests
Predicting patient response to immunotherapy treatment
Dr. Ofer Sharon discusses a new cancer research platform designed to improve patient outcomes, cut costs, and minimize unnecessary adverse events
6 upcoming webinars to help you reach your research goals
Discover the latest tools and techniques to expand your research capacity with expert-led presentations on laboratory automation, pipetting ergonomics, biomarker detection, and more
Oncomine Dx Target Test for Non-Small Cell Lung Cancer
Thermo Fisher ScientificOne test that can expedite NSCLC treatment selection decisions. The Oncomine Dx Target Test is the first targeted NGS-based in vitro diagnostic test for NSCLC, simultaneously delivering multiple biomarker results from one sample within four days and helping inform treatment decisions.
BioIVT acquires Tissue Solutions Ltd., a UK-based virtual biobank
This transaction will expand BioIVT’s biospecimen collection network by approximately 150 sites in the US, UK, and Europe and broaden its offerings for drug and diagnostic developers
Performance of immunotyping versus immunofixation for the detection of monoclonal gammopathies
Watch this on-demand webinar to find out the advantages of immunotyping over immunofixation in detecting M-proteins
Improving tissue models for drug screening and basic biology using 3D bioprinting
Discover how a laboratory in the US is harnessing extrusion- and light-based bioprinters to generate complex, anatomically accurate tissue models
The quest for experimental cancer therapeutics: Accelerating access to assay data
Find out about the 'revolutionary' technology enabling one lab to provide higher-quality, more timely data for cancer researchers





















